Publicacións en colaboración con investigadores/as de Complejo Hospitalario Torrecárdenas de Almería (22)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132

  3. Susceptibility to hepatitis B virus infection in adults living in Spain

    Liver International, Vol. 43, Núm. 5, pp. 1015-1020

  4. “Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study”

    European Journal of Surgical Oncology, Vol. 49, Núm. 10

2022

  1. Unhealthy food advertising. A position paper by the AEP Committee on nutrition and breastfeeding

    Anales de Pediatria, Vol. 97, Núm. 3, pp. 206.e1-206.e9

2021

  1. Impact of the first wave of the SARS-CoV-2 pandemic on the outcome of neurosurgical patients: A nationwide study in Spain

    BMJ Open, Vol. 11, Núm. 12

2019

  1. Identification of regulatory variants associated with genetic susceptibility to meningococcal disease

    Scientific Reports, Vol. 9, Núm. 1

  2. Plasma lipid profiles discriminate bacterial from viral infection in febrile children

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Antibody persistence and booster responses 24–36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial

    Journal of Infection, Vol. 76, Núm. 3, pp. 258-269

2017

  1. Circulating antibody 1 and 2 years after vaccination with the 13-valent pneumococcal conjugate vaccine in preterm compared with term infants

    Pediatric Infectious Disease Journal, Vol. 36, Núm. 3, pp. 326-332

  2. Whole Exome Sequencing reveals new candidate genes in host genomic susceptibility to Respiratory Syncytial Virus Disease

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Natural resistance to Meningococcal Disease related to CFH loci: Meta-analysis of genome-wide association studies

    Scientific Reports, Vol. 6

2015

  1. 13-Valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants

    Pediatrics, Vol. 135, Núm. 4, pp. e876-e886

  2. Viral co-infections in pediatric patients hospitalized with lower tract acute respiratory infections

    PLoS ONE, Vol. 10, Núm. 9

2014

  1. A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

    Vaccine, Vol. 32, Núm. 40, pp. 5206-5211

  2. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2013

  1. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain

    Vaccine, Vol. 31, Núm. 46, pp. 5486-5494

2011

  1. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine

    Vaccine, Vol. 29, Núm. 35, pp. 6042-6048

  2. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): Results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005

    British Journal of Haematology, Vol. 154, Núm. 5, pp. 600-611

2010

  1. Efectividad de palivizumab en la prevención de la infección por el virus respiratorio sincitial en prematuros de 321 a 35° semanas de gestación en España

    Acta Pediatrica Espanola, Vol. 68, Núm. 1, pp. 13-18